Genus plc
GENSF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.82B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.82 Billion |
|---|---|
| Enterprise Value | $1.89 Billion |
| Annual dividend | $0.43 |
| Dividend yield | 1.43% |
| Earnings per Share | $4.25 |
| Beta | 0.9 |
| Outstanding Shares | 66,540,000 |
Return
| Return on Equity | 39.73% |
|---|---|
| Return on Assets | 29.91% |
| Return on Invested Capital | 14.17% |
Valuation & Multiples
| P/E Ratio | 5.35 |
|---|---|
| PEG | 0.4 |
| Price to Sales | 1.41 |
| Price to Book Ratio | 2.56 |
| Enterprise Value to Revenue | 1.42 |
| Enterprise Value to EBIT | 14.82 |
| Enterprise Value to Net Income | 6 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.15 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 10, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
February 25, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Genus plc
3,307 employees
CEO: Jorgen Kokke
Genus plc is a global animal genetics company, with operations extending across North America, Latin America, the United Kingdom, broader Europe, the Middle East, Russia, Africa, and Asia. The firm organizes its business into three prima...